Biopharmaceuticals, Discovery, Design and Delivery (BDDD)

University of Groningen > Faculty of Medical Sciences > Groningen University Institute for Drug Exploration (GUIDE) > Biopharmaceuticals, Discovery, Design and Delivery (BDDD)

  1. 2019
  2. Sun, J., Nagel, R., Zaal, E. A., Ugalde, A. P., Han, R., Proost, N., ... Agami, R. (2019). SLC1A3 contributes to L‐asparaginase resistance in solid tumors. The EMBO Journal, [e102147]. https://doi.org/10.15252/embj.2019102147
  3. van Velzen, A. J., Uges, J. W. F., Heijerman, H. G. M., Arets, H. G. M., Nuijsink, M., van der Wiel-Kooij, E. C., ... Janssens, H. M. (2019). Pharmacokinetics and safety of tobramycin nebulization with the I-neb® and PARI-LC Plus® in children with cystic fibrosis: a randomized, crossover study. British Journal of Clinical Pharmacology, 85(9), 1984-1993. https://doi.org/10.1111/bcp.13988
Previous 1 2 3 4 5 6 7 8 ...43 Next

ID: 34511